Julia Seitz

A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)

Marc Ychou, Jean‐Luc Raoul, Jean‐Yves Douillard et al. · Annals of Oncology · 2009 · 200 citations

Medicine, Oncology, Pharmacology +13

Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer

Hans‐Peter Sinn, Andreas Schneeweiß, Marius Keller et al. · BMC Cancer · 2017 · 91 citations · Full text

Medicine, Molecular Biology, Oncology +17

Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

Andreas Schneeweiß, Johannes Ettl, Diana Lüftner et al. · The Breast · 2020 · 58 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer

Katharina Smetanay, P. R. M. Nogueira Junio, Manuel Feißt et al. · Breast Cancer Research and Treatment · 2018 · 55 citations

Medicine, Oncology, Breast Oncology +10

CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer

Mario Hlevnjak, Markus Schulze, Shaymaa Elgaafary et al. · JCO Precision Oncology · 2021 · 45 citations · Full text

Medicine, Molecular Medicine, Oncology +17